Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
Delayed Nasdaq Stockholm  -  11:29:54 2023-06-02 am EDT
254.00 SEK   +1.07%
05/31Getinge to acquire High Purity New England, Inc., a leading provider of single-use solutions for bioprocessing applications
AQ
05/31Getinge AB (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million.
CI
05/24CombiGene to play an integral part in the development of a national infrastructure for ATMPs
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
05/29/2023 05/30/2023 05/31/2023 06/01/2023 06/02/2023 Date
252(c) 252.5(c) 249.5(c) 251.3(c) 254(c) Last
211 204 418 470 901 050 1 076 061 2 271 897 Volume
-0.59% +0.20% -1.19% +0.72% +1.07% Change
More quotes
Estimated financial data (e)
Sales 2023 30 150 M 2 797 M 2 797 M
Net income 2023 2 987 M 277 M 277 M
Net Debt 2023 933 M 86,5 M 86,5 M
P/E ratio 2023 23,4x
Yield 2023 1,75%
Sales 2024 31 721 M 2 943 M 2 943 M
Net income 2024 3 480 M 323 M 323 M
Net cash position 2024 2 009 M 186 M 186 M
P/E ratio 2024 20,0x
Yield 2024 2,01%
Capitalization 69 182 M 6 419 M 6 419 M
EV / Sales 2023 2,33x
EV / Sales 2024 2,12x
Nbr of Employees 11 056
Free-Float 80,0%
More Financials
Company
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination... 
More about the company
Ratings of Getinge AB
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about GETINGE AB
05/31Getinge to acquire High Purity New England, Inc., a leading provider of single-use solu..
AQ
05/31Getinge AB (OM:GETI B) entered into an agreement to acquire High Purity N..
CI
05/24CombiGene to play an integral part in the development of a national infrastructure for ..
AQ
05/02Getinge : Strong Q1 23 in spite of ACT headwinds
Alphavalue
04/28Getinge : Minutes of AGM 2023
PU
04/28Getinge : Årsstämmoprotokoll 2023
PU
04/28Getinge : partnership in India pioneers AI in the ICU
PU
04/27GETINGE AB : Ex-dividend day for final dividend
FA
04/26Resolutions at Getinge's Annual General Meeting 26 April 2023
AQ
04/26Getinge AB Approves Dividend, Payable on 4 May 2023
CI
04/26Transcript : Getinge AB, Q1 2023 Earnings Call, Apr 26, 2023
CI
04/26Medical gear Getinge's Q1 profit grows unexpectedly as demand recovers
RE
04/26Getinge Interim Report January-march : Increased sales, strengthened earnings and PMA appr..
AQ
04/26Getinge AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
04/26GETINGE AB : Slide show Q1
CO
More news
News in other languages on GETINGE AB
05/03Getinge AB : Socio de cirujanos y médicos
05/02Getinge AB : partenaire des chirurgiens et des cliniciens
05/02Getinge : Un premier trimestre 23 solide malgré les vents contraires de l'ACT
04/27La Tech qui cache la forêt
04/27Avis d'analystes du jour : Teleperformance, Dassault Systèmes, ..
More news
Analyst Recommendations on GETINGE AB
More recommendations
ETFs positioned on GETINGE ABETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
XACT OMXS30 ESG - SEK1.2%0.90%-NC
IShares MSCI Sweden ETF - USD0.92%0.99%Sweden
XACT Sverige - SEK0.83%0.97%Sweden
IShares OMX Stockholm Capped - SEK0.76%1.19%Sweden
Wealthsimple Developed Markets ex North Ame...0.5%-0.44%-NC
More ETFs positioned on GETINGE AB
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 254,00 SEK
Average target price 263,67 SEK
Spread / Average Target 3,81%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandstr÷m Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB17.43%6 419
PENUMBRA, INC.44.23%12 274
SHOCKWAVE MEDICAL, INC.40.63%10 590
MASIMO CORPORATION11.74%8 621
NOVOCURE LIMITED8.41%8 446
ASAHI INTECC CO., LTD.29.94%5 468
Secure and increase the performance of your investments with our team of experts at your side.
Securing my Investments
fermer